CONTOURA® Vision is state-of-the-art, topography-guided LASIK treatment that is the latest FDA approved LASIK eye surgery technology available in the U.S.

Why CONTOURA^® Vision?

This new technology has unique capabilities that provides Ophthalmologist, Ken Lindahl at the Rochester Eye and Laser Center, a greater degree of personalization.  No other LASIK procedure available in the U.S. is this precise and individualized. The procedure is redefining the term “quality of vision” with studies showing that many patients experienced better vision than they ever did with glasses or contact lenses.

PanOptix® Trifocal Intraocular Lens (IOL), the first and only trifocal lens for U.S. patients undergoing cataract surgery. PanOptix is clinically shown to deliver an exceptional combination of near, intermediate and distance vision while significantly reducing the need for glasses after cataract surgery.

We interviewed one of our PanOptix patients and here is what he said about his vision following surgery.

Keratoconus
[ k er-u h-toh-k oh-nuh s]

Keratoconus or “KC” is a non-inflammatory eye condition in which the normally round dome-shaped cornea progressively thins causing a cone-like bulge to develop. This results in significant visual impairment.